General susceptibility
First Line Treatment
Alternate Treatment
Pathogen Information
Aerobic gram-negative rod
Epidemiology
Associated Syndromes
Additional Information
IDSA guidelines recommend avoiding use of ciprofloxacin if MIC is 0.12 μg/ mL or higher even if the laboratory report identifies the isolate as susceptible